(Q45040968)

English

The effects of modifying in vivo cytochrome P450 3A (CYP3A) activity on etoricoxib pharmacokinetics and of etoricoxib administration on CYP3A activity.

scientific article published in October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

The effects of modifying in vivo cytochrome P450 3A (CYP3A) activity on etoricoxib pharmacokinetics and of etoricoxib administration on CYP3A activity (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Walter K. Kraft

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Scott A. Waldman

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Nancy G B Agrawal

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Catherine Z Matthews

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Ralph S Mazenko

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Eric J Woolf

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Arturo G Porras

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Xun Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Jutta L Miller

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Nicole Michiels

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Martin Wehling

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Armin Schultz

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Alice B Gottlieb

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Howard E Greenberg

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Sean P Curtis

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Keith M Gottesdiener

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

44

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1125-1131

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Review article: COX-II inhibitors--a new generation of safer NSAIDs?

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

Absorption, metabolism, and excretion of etoricoxib, a potent and selective cyclooxygenase-2 inhibitor, in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin.

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

The erythromycin breath test for the prediction of drug clearance

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

Concurrent administration of the erythromycin breath test (EBT) and oral midazolam as in vivo probes for CYP3A activity.

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

Effect of multiple doses of rifampin on the [14C N-methyl] erythromycin breath test in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man.

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

Characterization of etoricoxib, a novel, selective COX-2 inhibitor

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

Noninvasive tests of CYP3A enzymes

1 reference

https://api.crossref.org/works/10.1177%2F0091270004268129

21 January 2018

Identifiers

10.1177/0091270004268129

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15342613%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45040968&oldid=1525400161"